D.E. Shaw & Co
ALDR

D.E. Shaw & Co’s Alder Biopharmaceuticals ALDR Stock Holding History

D.E. Shaw & Co’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-20,000
Closed -$1.06M – 4007
2015
Q2 		$1.06M Buy
+20,000
New +$727K ﹤0.01% 2663

D.E. Shaw & Co's ALDR Position: Q4 2019 in Review

D.E. Shaw & Co sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 68,923 shares — an estimated $1.3M sold.

D.E. Shaw & Co first reported a position in ALDR in Q4 2014 and held it in 12 quarters. The position peaked at $2.06M in Q1 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • D.E. Shaw & Co reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • D.E. Shaw & Co sold 68,923 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.3M.
  • D.E. Shaw & Co first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 12 quarters.
  • D.E. Shaw & Co's Alder Biopharmaceuticals position peaked at $2.06M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.